Article
Clinical Manifestations, Mutational Analysis, and Immunological Phenotype in Patients With RAG1/2 Mutations: First Cases Series From Mexico and Description of Two Novel Mutations.
2021-02-17
Abstract excerpt
<title>Abstract</title> <p>Mutations in Recombinase Activating Genes 1 and 2 (<italic>RAG1/2</italic>) results in human severe combined immunodeficiency (SCID). The products of these genes, are essential for V(D)J rearrangement of the antigen receptors during lymphocyte development. Nonsense mutations in <italic>RAG1</italic> or <italic>RAG2</italic> are associated with the most severe clinical and immunological...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- e60ef08e-f95c-513a-aebd-12766f159049
- DOI
- 10.21203/rs.3.rs-202390/v1
